SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021463
Filing Date
2018-08-13
Accepted
2018-08-13 16:11:32
Documents
51
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q 2Q 2018 acer-10q_20180630.htm 10-Q 1264812
2 EX-31.1 acer-ex311_11.htm EX-31.1 17755
3 EX-31.2 acer-ex312_8.htm EX-31.2 17603
4 EX-32.1 acer-ex321_12.htm EX-32.1 7906
5 EX-32.2 acer-ex322_7.htm EX-32.2 7869
6 GRAPHIC gxezoywpul0a000001.jpg GRAPHIC 4140
  Complete submission text file 0001564590-18-021463.txt   3690444

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acer-20180630.xml EX-101.INS 572385
8 XBRL TAXONOMY EXTENSION SCHEMA acer-20180630.xsd EX-101.SCH 37924
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20180630_cal.xml EX-101.CAL 26095
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20180630_def.xml EX-101.DEF 90142
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20180630_lab.xml EX-101.LAB 263175
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20180630_pre.xml EX-101.PRE 186839
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 181012370
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1